Did you know you can now get UNLIMITED CE Hours for only $74.95?
Click Here to learn more.

CE Course Description

According to the 2019 National Survey on Drug Use and Health, over 1.6 million people in the United States have an opioid use disorder. Furthermore, recent data from the Centers for Disease Control and Prevention (CDC) suggests that overdose death rates related to opioids are on the rise. To help address the rising rates of opioid use and opioid-related overdose deaths, health care professionals are being asked to become familiar with the use of medication-assisted treatment (MAT) in emergency departments (EDs). With that in mind, this course reviews the use of MAT in EDs to build awareness among health care professionals so they may work to optimize patient care.

Author:  This publication was developed with significant contributions from Gail D’Onofrio, M.D., M.S. and Kathryn Hawk, M.D., M.H.S. The guidance is based, in part, on the thoughtful input of the Planning Committee and the Expert Panel on Use of Medications for Opioid Use Disorder in Emergency Departments from March through September 30, 2019. A series of Planning Committee meetings were held virtually over a period of several months, and the expert panel meeting was convened in North Bethesda, Maryland, by the Substance Abuse and Mental Health Services Administration (SAMHSA).

Recommended Citation:  Substance Abuse and Mental Health Services Administration: Use of Medication-Assisted Treatment in Emergency Departments. HHS Publication No. PEP21-PL-Guide-5 Rockville, MD: National Mental Health and Substance Use Policy Laboratory. Substance Abuse and Mental Health Services Administration, 2021.

References/Contributions by:

1. Wilson, N., Kariisa, M., Seth, P., Smith IV, H., & Davis, N. L. (2020). Drug and opioid involved overdose deaths—United States, 2017–2018. Morbidity and Mortality Weekly Report, 69(11), 290-297.
2. Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., ... & Walley, A. Y. (2018). Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Annals of internal medicine, 169(3), 137-145.
3. National Academies of Sciences, Engineering, and Medicine. (2018). Medication-Assisted Treatment for Opioid Use Disorder.
4. Morgan, J. R., Schackman, B. R., Weinstein, Z. M., Walley,A. Y.,& Linas, B. P.(2019). Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort. Drug and Alcohol Dependence, 200, 34-39. doi: 10.1016/j. drugalcdep.2019.02.031

Retrieved From: samhsa.gov/resource/ebp/use-medication-assisted-treatment-emergency-departments

CE Course Objectives

1. Examine the use of MAT in EDs.
2. Evaluate the evidence supporting the use of MAT in EDs, while obtaining insight into the medications used in MAT.
3. Recognize examples of ED-initiated buprenorphine programs.
4. Identify myths related to the implementation of evidence-based practices and programs, while obtaining insight into the resources that may be used to support greater access to and effective use of MAT in EDs. 

CE Outline and Main Points

1. Issue Brief: Use of Medication-Assisted Treatment in Emergency Departments
2. Medication-Assisted Treatment
3. The Evidence for Emergency Department-Initiated Medication-Assisted Treatment Disorder
4. Buprenorphine Formulations for the Treatment of Opioid Use Disorder
5. Medication-Assisted Treatment in the Emergency Department
6. Frequently-Asked Questions: Emergency Department-Initiated Buprenorphine
7. Tips for Successful Adoption of Emergency Department-Initiated Buprenorphine
8. Conclusion

ACE credit is not offered for this course. A list of courses offering ACE credit can be found here.

Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional and licensed expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degrees of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff and their bios here.

*Questions regarding how to take a course, refunds, grievance policy and ADA policy can be found here.
*Questions regarding this course or need support? Contact us at support@quantumunitsed.com.

Added On: 01/01/2021